6 investors discuss why AI is more than just a buzzword in biotech

6 investors discuss why AI is more than just a buzzword in biotech

To get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today.

6 investors discuss why AI is more than just a buzzword in biotech by Anna Heim originally published on TechCrunch

6 investors discuss why AI is more than just a buzzword in biotech

2022-12-16 06:03